The Library

The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population

Tools

Rees, Simon D., Britten, Abigail C., Bellary, Srikanth, O'Hare, J. Paul, Kumar, Sudhesh, Barnett, A. H. and Kelly, M. Ann. (2009) The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population. BMC Medical Genetics, Vol.10 . p. 83. ISSN 1471-2350

Preview

Text
WRAP_Kumar_polymorphism.pdf - Draft Version
Download (286Kb)

Official URL: http://dx.doi.org/10.1186/1471-2350-10-83

Abstract

Background

The PCK1 gene, encoding cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C), has previously been implicated as a candidate gene for type 2 diabetes (T2D) susceptibility. Rodent models demonstrate that over-expression of Pck1 can result in T2D development and a single nucleotide polymorphism (SNP) in the promoter region of human PCK1 (-232C/G) has exhibited significant association with the disease in several cohorts. Within the UK-resident South Asian population, T2D is 4 to 6 times more common than in indigenous white Caucasians. Despite this, few studies have reported on the genetic susceptibility to T2D in this ethnic group and none of these has investigated the possible effect of PCK1 variants. We therefore aimed to investigate the association between common variants of the PCK1 gene and T2D in a UK-resident South Asian population of Punjabi ancestry, originating predominantly from the Mirpur area of Azad Kashmir, Pakistan.
Methods

We used TaqMan assays to genotype five tagSNPs covering the PCK1 gene, including the -232C/G variant, in 903 subjects with T2D and 471 normoglycaemic controls.
Results

Of the variants studied, only the minor allele (G) of the -232C/G SNP demonstrated a significant association with T2D, displaying an OR of 1.21 (95% CI: 1.03 - 1.42, p = 0.019).
Conclusion

This study is the first to investigate the association between variants of the PCK1 gene and T2D in South Asians. Our results suggest that the -232C/G promoter polymorphism confers susceptibility to T2D in this ethnic group.

Item Type:

Journal Article

Subjects:

R Medicine > RC Internal medicine

Divisions:

Faculty of Medicine > Warwick Medical School > Translational & Systems Medicine > Metabolic and Vascular Health
Faculty of Medicine > Warwick Medical School

Library of Congress Subject Headings (LCSH):

Non-insulin-dependent diabetes -- Great Britain, Diabetes -- Genetic aspects -- Research, South Asians -- Health and hygiene -- Great Britain, Chromosome polymorphism

Journal or Publication Title:

BMC Medical Genetics

Publisher:

BioMed Central Ltd.

ISSN:

1471-2350

Official Date:

2 September 2009

Dates:

Date	Event
2 September 2009	Published

Volume:

Vol.10

Page Range:

p. 83

Identification Number:

10.1186/1471-2350-10-83

Status:

Peer Reviewed

Publication Status:

Published

Access rights to Published version:

Open Access

References:

1. Valera A, Pujol A, Pelegrin M, Bosch F: Transgenic mice overexpressing
phosphoenolpyruvate carboxykinase develop noninsulin-
dependent diabetes mellitus. Proc Natl Acad Sci USA
1994, 91:9151-9154.
2. Hani EH, Zouali H, Philippi A, Beaudoin JC, Vionnet N, Passa P,
Demenais F, Froguel P: Indication for genetic linkage of the
phosphoenolpyruvate carboxykinase (PCK1) gene region on
chromosome 20q to non-insulin-dependent diabetes mellitus.
Diabetes Metab 1996, 22:451-454.
3. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F,
Froguel P: A susceptibility locus for early-onset non-insulin
dependent (type 2) diabetes mellitus maps to chromosome
20q, proximal to the phosphoenolpyruvate carboxykinase
gene. Hum Mol Genet 1997, 6:1401-1408.
4. Cao H, van der Veer E, Ban MR, Hanley AJ, Zinman B, Harris SB, Young
TK, Pickering JG, Hegele RA: Promoter polymorphism in PCK1
(phosphoenolpyruvate carboxykinase gene) associated with
type 2 diabetes mellitus. J Clin Endocrinol Metab 2004, 89:898-903.
5. Shin HD, Park BL, Kim LH, Cheong HS, Kim JH, Cho YM, Lee HK, Park
KS: Association of a polymorphism in the gene encoding phosphoenolpyruvate
carboxykinase 1 with high-density lipoprotein
and triglyceride levels. Diabetologia 2005, 48:2025-2032.
6. Willer CJ, Bonnycastle LL, Conneely KN, Duren WL, Jackson AU,
Scott LJ, Narisu N, Chines PS, Skol A, Stringham HM, et al.: Screening
of 134 single nucleotide polymorphisms (SNPs) previously
associated with type 2 diabetes replicates association
with 12 SNPs in nine genes. Diabetes 2007, 56:256-264.
7. Dong Y, Zhang H, Wang X, Feng Q, Chen X, Su Q: A Leu184Val
polymorphism in PCK1 gene is associated with type 2 diabetes
in Eastern Chinese population with BMI<23 kg/m2. Diabetes
Res Clin Pract 2009, 83:227-232.
8. Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W:
Association of the promoter polymorphism -232C/G of the
phosphoenolpyruvate carboxykinase gene (PCK1) with Type
2 diabetes mellitus. Diabet Med 2006, 23:419-425.
9. Wegner L, Andersen G, Albrechtsen A, Sparso T, Glumer C, Borch-
Johnsen K, Jorgensen T, Hansen T, Pedersen O: Large-scale study
of the -232C > G polymorphism of PCK1 in Type 2 diabetes.
Diabet Med 2006, 23:1140-1144.
10. Barnett AH, Dixon AN, Bellary S, Hanif MW, O'Hare JP, Raymond
NT, Kumar S: Type 2 diabetes and cardiovascular risk in the
UK south Asian community. Diabetologia 2006, 49:2234-2246.
11. Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughal S, Szczepura
A, Kumar S, Barnett AH: Enhanced diabetes care to patients of
south Asian ethnic origin (the United Kingdom Asian Diabetes
Study): a cluster randomised controlled trial. Lancet 2008,
371:1769-1776.
12. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization
of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
13. The International HapMap Consortium: The International Hap-
Map Project. Nature 2003, 426:789-796.
14. Purcell S, Cherny SS, Sham PC: Genetic Power Calculator:
design of linkage and association genetic mapping studies of
complex traits. Bioinformatics 2003, 19:149-150.
15. Rees SD, Bellary S, Britten AC, O'Hare JP, Kumar S, Barnett AH, Kelly
MA: Common variants of the TCF7L2 gene are associated
with increased risk of type 2 diabetes mellitus in a UK-resident
South Asian population. BMC Med Genet 2008, 9:8.
16. Beale EG, Hammer RE, Antoine B, Forest C: Disregulated glyceroneogenesis:
PCK1 as a candidate diabetes and obesity gene.
Trends Endocrinol Metab 2004, 15:129-135.
17. Gomez-Valades AG, Mendez-Lucas A, Vidal-Alabro A, Blasco FX,
Chillon M, Bartrons R, Bermudez J, Perales JC: Pck1 gene silencing
in the liver improves glycemia control, insulin sensitivity, and
dyslipidemia in db/db mice. Diabetes 2008, 57:2199-2210.
18. Voight BF, Pritchard JK: Confounding from cryptic relatedness
in case-control association studies. PLoS Genet 2005, 1:e32.